Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer

PURPOSE: Hypertension (HTN) is frequently associated with the use of angiogenesis inhibitors targeting the vascular endothelial growth factor pathway, such as ramucirumab. The aim of this study was to retrospectively evaluate if occurrence of HTN is correlated with response to second line treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Roviello, Giandomenico, Corona, Silvia Paola, Multari, Andrea Giovanni, Paganini, Giovanni, Chiriacò, Giorgio, Conca, Raffaele, Petrioli, Roberto, Generali, Daniele, Rosellini, Pietro, Aieta, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976467/
https://www.ncbi.nlm.nih.gov/pubmed/29854281
http://dx.doi.org/10.18632/oncotarget.24900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976467/
https://www.ncbi.nlm.nih.gov/pubmed/29854281
http://dx.doi.org/10.18632/oncotarget.24900

Ejemplares similares